| Title: |
Access Denied? The Unintended Consequences of Pending Drug Pricing Rules |
| Authors: |
Kaplan, Alan; Stewart, David J.; Batist, Gerald; Spadafora, Silvana; Sehdev, Sandeep; Goodman, Shaun G. |
| Publisher Information: |
University of Toronto |
| Publication Year: |
2022 |
| Collection: |
University of Toronto: Research Repository T-Space |
| Description: |
The government of Canada now plans to bring into force new federal drug pricing regulations on 1 July 2022. We do not take issue with the goal of medication affordability, which is vital in healthcare the world over. Our concern is that the new guidelines are being implemented without due consideration for three major unintended consequences: regulatory changes will lower the number of clinical trials for new medications in Canada, fewer clinical trials will mean lower research and development investments, and changes will reduce patients’ access to new medications. Access to effective medications is a cornerstone of healthcare for Canadian patients. As physicians, our duty to patient care demands that we tell the government to protect the right of Canadians to timely access to life-changing medicines. |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
unknown |
| Relation: |
http://hdl.handle.net/1807/111032 |
| DOI: |
10.3390/curroncol29040204 |
| Availability: |
http://hdl.handle.net/1807/111032; https://doi.org/10.3390/curroncol29040204 |
| Rights: |
Attribution 4.0 International ; https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.9D536400 |
| Database: |
BASE |